Navigation Links
Ambrx Enters FGF-21 Type 2 Diabetes Drug Discovery Collaboration with Merck and Co. Inc.
Date:12/18/2007

g option. Additional terms of the agreement were not disclosed. It is expected that this collaboration, in conjunction with three others announced this year, will preclude the necessity for Ambrx to raise additional equity capital for a number of years.

About Ambrx

Ambrx Inc. is a biopharmaceutical company focused on the discovery and development of first-in-class and best-in-class BioSuperior(TM), protein-based drugs. Using its technology, the company can overcome the performance limitations of high-value commercial proteins by improving their efficacy, safety and ease of use. Ambrx's core ReCODE(TM) technology enables the precise, site-specific substitution of a novel amino acid within a protein. This allows the conjugation of proteins with additional molecules that can serve to modulate their pharmacokinetic profile or biological function. Ambrx's ReCODE(TM) technology is applicable to multiple protein products across numerous therapeutic areas. Ambrx has successfully and rapidly applied its innovative technology platform to advance into the clinic with ARX201, its first proprietary molecule, and is building a broad pipeline of additional product opportunities. For additional information, call 858.875.2400 or visit http://www.ambrx.com.


'/>"/>
SOURCE Ambrx Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Kosans Motilin Receptor Agonist, Licensed to Pfizer, Enters Phase 1 Clinical Trial in Gastroesophageal Reflux Disease
2. The Heart, Diabetes, And Weight Loss Centers of New York Introduce the New Science of Metabolic Diagnosis and Weight Management
3. CellCyte Genetics Corp. Enters Collaborative Research Agreement With Cleveland Clinic Foundation to Qualify Stem Cell Delivery in Damaged Heart Tissue
4. Cepheid Announces Termination of Contract With the Centers for Disease Control and Prevention to Develop Rapid Point of Care Test for Avian Influenza
5. Preimplantation Genetic Diagnosis International Society Refutes American Society of Reproductive Medicine Opinion - States Preimplantation Genetic Screening is Beneficial When Performed in Experienced Centers
6. Concentra Medical Centers Gears Up for Flu Season to Keep Area Workforce Healthy
7. MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus
8. Sarasotas Roskamp Institute Releases Study Defining a Mechanism for Development of Obesity and the Metabolic Syndrome, Forerunners of Type 2 Diabetes
9. Isis Initiates Phase 1 Study of ISIS 325568 Targeting Glucagon Receptor to Treat Type 2 Diabetes
10. Diabetes Research Institute Invention Promotes Growth of Stem Cells into Insulin-Producing Cells
11. Cleveland Clinic Study Shows the Diabetes Drug Pioglitazone Reduces Risk of Death, Heart Attack and Stroke, but Increases Risk of Heart Failure
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... and STAMFORD, Conn. , Aug. 31, ... Eisai Co., Ltd., and Purdue Pharma L.P. announced today ... for the development and commercialization of Eisai,s clinical candidate ... entering Phase III clinical development for the treatment of ... agreement, Eisai and Purdue Pharma will share the costs ...
(Date:8/31/2015)... Aug. 31, 2015 Research and Markets ... the "Prescription Pain Drugs - Including Opioid, ... Global Markets, Competitors and Opportunities: 2015 - 2020 ... Pain is defined as an ... or potential tissue damage. At some point, everyone ...
(Date:8/28/2015)... Fla. , Aug. 28, 2015  With the ... reaching deadlier heights, Jacksonville -based ... Philip Hemphill is helping to explain why fentanyl ... is approximately 40 to 50 times more potent than ... recreational users as heroin, the risk of death skyrockets. ...
Breaking Medicine Technology:Eisai and Purdue Pharma Enter Worldwide Collaboration to Develop and Commercialize Lemborexant 2Eisai and Purdue Pharma Enter Worldwide Collaboration to Develop and Commercialize Lemborexant 3Eisai and Purdue Pharma Enter Worldwide Collaboration to Develop and Commercialize Lemborexant 4Eisai and Purdue Pharma Enter Worldwide Collaboration to Develop and Commercialize Lemborexant 5Prescription Pain Drugs Including Opioid, Anticonvulsant, Injectable/ Inhaled, Topical/ Transdermal, Medical Marijuana - 2015-2020 Analysis and Forecasts 2Prescription Pain Drugs Including Opioid, Anticonvulsant, Injectable/ Inhaled, Topical/ Transdermal, Medical Marijuana - 2015-2020 Analysis and Forecasts 3Lakeview Health's Dr. Philip Hemphill Explains Why Heroin Addicts Are Now Dying of Fentanyl Overdoses 2
(Date:8/31/2015)... Pittsburgh, PA (PRWEB) , ... August 31, 2015 ... ... television than their peers may be at a greater risk for injury, potentially ... risk-taking behaviors, a University of Pittsburgh Graduate School of Public Health analysis discovered. ...
(Date:8/31/2015)... ... August 31, 2015 , ... Kognito , a ... their competencies in managing challenging conversations, announced today that Glenn Albright, Ph.D., the ... of Excellence for Psychological Health and Traumatic Brain Injury (DCoE) Summit taking ...
(Date:8/31/2015)... ... August 31, 2015 , ... On Saturday, May 30th, 2015, Best ... Adams County Fairgrounds in Mendon, IL. The purpose behind this concert was to raise ... neighboring town, Quincy. Best Drug Rehabilitation’s sponsorship of “Music with a Mission” helped with ...
(Date:8/31/2015)... , ... August 31, 2015 , ... ... e-Spirit to future-proof its content management system (CMS) and make website updates quicker ... Sports in making the websites of the Bundesliga (the German equivalent of the ...
(Date:8/31/2015)... ... 2015 , ... “My mother and husband use oxygen therapy and the tubing ... there could be a comfortable way to prevent the irritation, so I invented this.” ... a more secure way to anchor the cannula tubing used in oxygen therapy and ...
Breaking Medicine News(10 mins):Health News:Television Viewing Linked to Higher Injury Risk in Hostile People 2Health News:Television Viewing Linked to Higher Injury Risk in Hostile People 3Health News:Kognito’s Glenn Albright to Present at DCoE Summit 2Health News:2015 "Music With A Mission" Sponsor Best Drug Rehabilitation Releases Artist Compilation Video 2Health News:2015 "Music With A Mission" Sponsor Best Drug Rehabilitation Releases Artist Compilation Video 3Health News:On the Ball with FirstSpirit: German Soccer League (DFL Digital Sports) Opts for e-Spirit’s CMS 2Health News:InventHelp® Inventor Designs Nasal Cannula Ear Protector (AVZ-1217) 2
... Babies born to HIV-positive mothers and given the antiretroviral ... to prevent infection via breast-feeding are at high risk ... a team of researchers report. But the investigators highlight ... mother-to-child HIV transmission in breast-fed infants. , ...
... Corporation (NYSE: CBM ) is pleased ... Chief Executive Officer, will be presenting at the ... 9:00 a.m. PST at the Westin St. Francis, ... http://www.newscom.com/cgi-bin/prnh/20000613/CAMBREXLOGO )A live webcast of the presentation ...
... Jan. 5 Volcano Corporation,(Nasdaq: VOLC ), ... for the diagnosis and treatment of coronary and peripheral ... January 6, to,discuss its acquisition of Axsun Technologies, Inc., ... The teleconference call and webcast will begin ...
... Few things are as tiresome as house hunting and ... down pat. Tripping nimbly from one abode to another, ... than the original tumor. Although little has been known ... down roots, researchers at the Stanford University School of ...
... the U.S. each year have been exposed to alcohol or illicit ... the National Center on Substance Abuse and Child Welfare. If removed ... in foster care longer, and chances are very low that they ... led by Joseph P. Ryan, a faculty member in the School ...
... with Operation Smile to See the Difference, Make a ... through March 2009, Crest and Oral-B are encouraging people across the ... while also making a difference in children,s smiles worldwide. When ... difference in their smile. People can also make a ...
Cached Medicine News:Health News:Prolonged nevirapine in breast-fed babies prevents HIV infection but leads to drug-resistant HIV 2Health News:Prolonged nevirapine in breast-fed babies prevents HIV infection but leads to drug-resistant HIV 3Health News:Reminder: Volcano Corporation Schedules Conference Call, Webcast to Discuss Axsun Transaction 2Health News:'Relocation' plan of metastatic cancer cells uncovered by Stanford researchers 2Health News:'Recovery coaches' effective in reducing number of babies exposed to drugs 2Health News:'Recovery coaches' effective in reducing number of babies exposed to drugs 3Health News:Crest and Oral-B Challenge America to See The Difference in Their Smile and Make A Difference in Children's Smiles Around the World 2Health News:Crest and Oral-B Challenge America to See The Difference in Their Smile and Make A Difference in Children's Smiles Around the World 3Health News:Crest and Oral-B Challenge America to See The Difference in Their Smile and Make A Difference in Children's Smiles Around the World 4
Low Profile Design for Precise Anchor Placement...
... utilizes a suprapubic approach to treat ... urethral hypermobility and/or intrinsic sphincter deficiency ... needles and a self-fixating sling with ... for intra-operative tension refinement without mesh ...
... The Uretex® Trans-Obturator ... excellent tension-free, self-anchoring support ... The polypropylene mesh maintains ... flat placement under the ...
... Delivers the durability of natural ... benefits of ingrowth and natural ... or exceeds all applicable state ... Allograft Tissue also reduces OR ...
Medicine Products: